| |
|
|
|
ImmuCell Corporation  
|
|
9.95 -0.22 (-0.02%) |
09-21 09:30 |
|
Open: |
9 |
Pre close: |
10.17 |
Target:
|
12.00 
|
|
High: |
9.95 |
Low: |
9.95 |
Resistance:
|
10.27
12.00
|
|
Volume: |
241 |
Market Cap: |
77M |
Support:
|
8.43
7.30
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
9.61
|
MACD |
MACD(12,26):
|
0.09 |
|
MA(20): |
9.09 |
Signal(12,26,9): |
-0.04 |
|
MA(100): |
9.59  |
Stochastic Oscillator |
%K(14,3):
|
76.32 |
|
MA(250): |
8.48 |
%D(3): |
69.21 |
|
Average Volume(K) |
3-Month: |
43642
|
52-Week |
High:
|
13.20 |
|
10-Days: |
1112 |
Low: |
5.01 |
|
RSI |
RSI(14):
|
59.62 |
Change(%): |
92.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.140 |
Return on Equity (ttm) |
-4.7 |
Shares Out. (M) |
7.74 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-3.1 |
Shares Float (M) |
5.17 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
28.62 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-16.4 |
% Held by Institutions |
10.19 |
|
Forward EPS |
-0.030 |
Gross Profit (p.s.) |
0.886 |
Shares Short (K) |
13 |
|
Book Value (p.s.) |
3.920 |
EBITDA (p.s.) |
0.059 |
P/E |
-72.64 |
|
Sales Per Share |
1.879 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.59 |
|
Profit Margin |
-9.23 |
Operating Cash Flow
(M) |
-0.17 |
P/S |
5.41 |
|
Operating Margin |
-13.43 |
Levered Free Cash Flow
(M) |
-3.00 |
P/CF |
-475.85 |
|
|
|
|
|
|
